Abstract
Background Diabetes mellitus(DM) has become the third chronic noncommunicable disease worldwide, and is one of the most common chronic diseases in almost all countries. Type 2 diabetes(T2DM) is the most common group of DM, accounting for more than 90% of the DM population.
Objectives This systematic review is conducted to compare the impact of HIIT and MICT on body composition and glucose control in T2DM, and to determine the suitable intervention for HIIT and the more effective forms of HIIT on T2DM.
Methods Seven databases were searched from their inception to 21 November 2022 for randomized controlled trial(RCT) with HIIT and MICT intervention. The effect size was completed by using standardized mean difference (SMD) and standard deviation. Body mass(BM), body mass index (BMI), percent fat mass (PFM), fat mass (FM), fat-free mass (FFM), VO2peak, HbA1c, fasting plasma glucose(FPG), and fasting plasma insulin(FPI) were included in the meta-analysis as outcomes.
Results 15 RCTs with 371 T2DM were conducted in accordance with our inclusion criteria. The results of the meta-analysis revealed that compared to MICT, HIIT had significant effects on VO2peak(SMD=0.4, 95%CI: 0.08 to 0.73, p=0.02) and HbA1c(SMD=-0.24, 95%CI: -0.48 to -0.01, p=0.04), while there were no significant differences in body composition, FPG, and FPI.
Conclusion HIIT provides similar or more benefits on body composition, cardiorespiratory fitness(CRF), and glucose control relative to MICT, which might be influenced by duration, frequency, and HIIT interval. For people with T2DM, HIIT can achieve more improvement in CRF and glucose control than MICT and appear to be more time-saving.
Competing Interest Statement
The authors have declared that no competing interests exist.
Funding Statement
This research was supported by grants from Scientific Research project of Hunan Provincial Department of Education (20C1429) and Teaching reform project of Hunan University of Chinese Medicine (2021-JG045).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
c1978477400{at}126.com
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
